Inotiv(NOTV)

Search documents
Inotiv(NOTV) - 2021 Q2 - Quarterly Report
2021-05-14 18:13
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2021 OR (State or other jurisdiction of incorporation or organization) 2701 KENT AVENUE WEST LAFAYETTE, INDIANA (Address of principal executive offices) (765) 463-4527 (Registrant's telephone number, including area code) ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITI ...
Inotiv(NOTV) - 2021 Q2 - Earnings Call Transcript
2021-05-08 15:13
Inotiv, Inc. (NASDAQ:NOTV) Q2 2021 Earnings Conference Call May 5, 2021 4:30 PM ET Company Participants Kalle Ahl - IR, The Equity Group Robert Leasure Jr. - President and CEO Beth A. Taylor - VP, Finance and CFO John Sagartz - Chief Strategy Officer Conference Call Participants Unidentified Analyst - Operator Greetings and welcome to Inotiv???s Second Quarter Fiscal 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow t ...
Inotiv(NOTV) - 2021 Q1 - Quarterly Report
2021-02-10 21:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended December 31, 2020 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from ___________ to _____________. Commission File Number 000-23357 BIOANALYTICAL SYSTEMS, INC. (Exact name of the registrant as specified in its charter) INDIA ...
Inotiv(NOTV) - 2021 Q1 - Earnings Call Transcript
2021-02-10 03:15
Bioanalytical Systems, Inc. (BASI) Q1 2021 Results Conference Call February 9, 2021 4:30 PM ET Company Participants Kalle Ahl - IR, The Equity Group Bob Leasure - President and CEO Beth Taylor - CFO John Sagartz - Chief Strategy Officer Conference Call Participants David Windley - Jefferies Lenny Dunn - Mutual Trust Company Operator Greetings and welcome to Bioanalytical Systems, Inc.???s First Quarter Fiscal 2021 Financial Results Call. At this time, all participants are in a listen-only mode. A question-a ...
Inotiv(NOTV) - 2020 Q4 - Annual Report
2020-12-22 22:21
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended September 30, 2020. OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from ___________ to _____________. Commission File Number 000-23357 BIOANALYTICAL SYSTEMS, INC. (Exact name of the registrant as specified in its charter) INDIANA (St ...
Inotiv(NOTV) - 2020 Q3 - Quarterly Report
2020-08-14 18:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended June 30, 2020 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to . Commission File Number 000-23357 BIOANALYTICAL SYSTEMS, INC. (Exact name of the registrant as specified in its charter) INDIANA (State or other jurisdicti ...
Inotiv(NOTV) - 2020 Q2 - Quarterly Report
2020-05-14 18:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2020 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to . Commission File Number 000-23357 BIOANALYTICAL SYSTEMS, INC. (Exact name of the registrant as specified in its charter) INDIANA (State or other jurisdict ...
Inotiv(NOTV) - 2020 Q1 - Quarterly Report
2020-02-14 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended December 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from ___________ to _____________. Commission File Number 000-23357 BIOANALYTICAL SYSTEMS, INC. (Exact name of the registrant as specified in its charter) INDIA ...
Inotiv(NOTV) - 2019 Q4 - Annual Report
2019-12-26 21:56
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 OR FORM 10-K ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from ___________ to _____________. (Mark Commission File Number 000-23357 One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended September 30, 2019. BIOANALYTICAL SYSTEMS, INC. (Exact name of the registrant as specified in its charter) INDIANA (St ...
Inotiv(NOTV) - 2019 Q3 - Quarterly Report
2019-08-14 19:32
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from ___________ to _____________. Commission File Number 000-23357 BIOANALYTICAL SYSTEMS, INC. (Exact name of the registrant as specified in its charter) INDIANA (State or other jurisdiction of incorporation or organization) 2701 KENT AVENUE WEST LAFAYETTE, INDIANA (Address of principal executive offices) (765) ...